Analysts have been eager to weigh in on the Real Estate sector with new ratings on Medical Properties (MPW – Research Report), Crown Castle (CCI – Research Report) and RioCan Real Estate Investment (RIOCF – Research Report).
Medical Properties (MPW)
In a report issued on February 16, Michael Carroll from RBC Capital maintained a Buy rating on Medical Properties, with a price target of $5.00. The company’s shares closed last Friday at $3.56, close to its 52-week low of $2.92.
According to TipRanks.com, Carroll is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Medical Properties with a $4.43 average price target.
See today’s best-performing stocks on TipRanks >>
Crown Castle (CCI)
In a report issued on February 16, Jonathan Atkin from RBC Capital maintained a Hold rating on Crown Castle, with a price target of $92.00. The company’s shares closed last Friday at $108.22.
Atkin has an average return of
According to TipRanks.com, Atkin is ranked #117 out of 8727 analysts.
Currently, the analyst consensus on Crown Castle is a Moderate Buy with an average price target of $117.23.
RioCan Real Estate Investment (RIOCF)
In a report issued on February 18, Pammi Bir from RBC Capital maintained a Buy rating on RioCan Real Estate Investment, with a price target of C$22.00. The company’s shares closed last Friday at $13.74.
According to TipRanks.com, Bir is ranked #1289 out of 8727 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for RioCan Real Estate Investment with a $15.80 average price target, implying a 15.2% upside from current levels. In a report issued on February 14, Canaccord Genuity also maintained a Buy rating on the stock with a C$20.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MPW:
